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Homeostasis of lymphocyte numbers is believed to be due to competition between cellular
populations for a common niche of restricted size, deﬁned by the combination of interac-
tions and trophic factors required for cell survival. Here we propose a new mechanism:
homeostasis of lymphocyte numbers could also be achieved by the ability of lymphocytes
to perceive the density of their own populations. Such a mechanism would be reminiscent
of the primordial quorum-sensing systems used by bacteria, in which some bacteria sense
the accumulation of bacterial metabolites secreted by other elements of the population,
allowing them to “count” the number of cells present and adapt their growth accordingly.
We propose that homeostasis of CD4+T cell numbers may occur via a quorum-sensing-like
mechanism, where IL-2 is produced by activated CD4+T cells and sensed by a population of
CD4+Treg cells that expresses the high-afﬁnity IL-2Rα-chain and can regulate the number of
activated IL-2-producing CD4+ T cells and the total CD4+ T cell population. In other words,
CD4+ T cell populations can restrain their growth by monitoring the number of activated
cells, thus preventing uncontrolled lymphocyte proliferation during immune responses.We
hypothesize that malfunction of this quorum-sensing mechanism may lead to uncontrolled
T cell activation and autoimmunity. Finally, we present amathematical model that describes
the key role of IL-2 and quorum-sensing mechanisms in CD4+ T cell homeostasis during
an immune response.
Keywords: CD4+ T cells, regulatory T cells, IL-2, autoimmunity, immune-therapy, homeostasis, quorum sensing,
mathematical modeling
INTRODUCTION TO CD4+ T CELL HOMEOSTASIS
As in other organs and tissues of the body, the number of cells of
the immune system is typically maintained throughout the adult
life of an individual. This type of control is akin to the mecha-
nisms that act to maintain nutrient levels or temperature, which
were ﬁrst identiﬁed by Bernard (1865) and later termed home-
ostasis (Cannon, 1932). T cell numbers are essentially maintained
at a stable level throughout adult life, despite their daily produc-
tion and export from the thymus and their peripheral division.
The contribution of the thymus to the establishment and mainte-
nance of T cell numbers in peripheral pools has been quantiﬁed
(Metcalf, 1965; Miller, 1965; Leuchars et al., 1978; Berzins et al.,
1998; Almeida et al., 2001). The degree of thymus restoration is
determined by the availability of competent precursors, but the
number of peripheral T cells is largely independent of the number
of thymus precursor cells, for example, mice with reduced thymus
production showed replete peripheral compartments (Almeida
et al., 2001). These experimental ﬁndings have indicated that
T cell numbers are controlled by peripheral mechanisms, and
lead to the suggestion that competition is an important factor
in maintaining T cell homeostasis. Indeed, in normal mice with
full thymus production, if the generation of newT cells exceeds the
minimal requirements to ﬁll the peripheral pools and their overall
peripheral number is kept constant, it follows that each newly gen-
erated cell must compete for survival with other newly produced
or resident cells (Freitas et al., 1996; Freitas and Rocha, 2000).
Therefore, lymphocyte survival in peripheral pools is not a pas-
sive phenomenon, but rather a continuous active process driven
by highly selective environmental cues (Freitas et al., 1996; Freitas
and Rocha, 2000). However, all T cells are not equal; the periph-
eral T cell pool is composed of a diverse set of subpopulations
that play different essential roles in establishing immune responses
and immune-competence. Thus, the mechanisms responsible for
guiding the survival and homeostasis of peripheral T cell numbers
must include a qualitative dimension, allowing for the coexistence
of different T cell populations (Almeida et al., 2005). How is this
achieved?
The peripheral αβ TCR+ T cell pool can be divided into CD4+
“helper”andCD8+ “cytotoxic”T cells, and each of these twomajor
subpopulations consists of naïve (not having encountered antigen)
and activated/memory (antigen-experienced) pools. These pop-
ulations represent the potential to react to newly encountered
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antigens, and to provide fast and efﬁcient responses to recurrent
antigens, respectively. For naïve T cells, the trophic survival signals
are contingent on TCR-mediated signals upon interactions with
MHC Class-I or MHC Class-II molecules, and on γc-dependent
cytokines, namely IL-7 (Surh and Sprent, 2008). The roles of TCR
signals andTCR-MHC interactionswere demonstrated by transfer
of T cells to MHC-devoid hosts (Takeda et al., 1996; Brocker, 1997;
Kirberg et al., 1997; Tanchot et al., 1997) and by ablation of TCRs
(Labrecque et al., 2001); both approaches resulted in the loss of T
cells. IL-7-dependency was shown upon either transferring T cells
into IL-7-deﬁcient animals (Schluns et al., 2000; Tan et al., 2001) or
treatment of host animals with anti-IL-7 antibodies (Vivien et al.,
2001); again, both approaches resulted in T cell death. IL-7 also
modulates MHC Class-II expression in dendritic cells, establish-
ing a relationship between cytokines and TCR-mediated signals
in naïve CD4+ T cell homeostasis (Guimond et al., 2009). IL-7 is
present in the secondary lymph nodes (LN), where it is produced
by ﬁbroblastic reticular cells (FRCs; Link et al., 2007). Expression
of the CD62L and CCR7 homing receptors allow T cells to fol-
low gradients of CCL19 and CCL21 chemokines made by the LN
stromal cells, and thus access IL-7. Interestingly, the transcription
factor Foxo1 regulates expressions of IL-7R, CD62L, and CCR7
in naïve T cells (Freitas and Rocha, 2009; Kerdiles et al., 2009;
Ouyang et al., 2009), establishing a close link between lympho-
cyte migration and survival. Migration ensures the distribution of
lymphocytes between different environments and allows the cells
to ﬁnd the appropriate niche for survival.
Memory T cells have less stringent requirements for survival.
CD8+ memory T cells can survive in absence of the restricting
MHC Class-I element (Tanchot et al., 1997), while the survival of
CD4+ memory T cells is MHC Class-II independent (Swain et al.,
1999; Polic et al., 2001). Thus,memoryT cell survival seemsmostly
dependent on IL-7 and IL-15 (Surh and Sprent, 2008).While there
is some degree of overlap in survival signals, naïve, and memory T
cells do not seem to compete, allowing for the coexistence of these
populations. This was shown in studies where animals manipu-
lated to have only naïve CD8+ T cells showed halved total CD8+ T
cell numbers, as well as in studies where animals with only mem-
ory T cells were unable to ﬁll up the entire T cell pool (Tanchot
and Rocha, 1995; Freitas and Rocha, 2000). Coexistence of these
populations is ensured through a mechanism of niche segrega-
tion; separated control of these populations ensures that both are
maintained, and avoids competition between them (Tanchot et al.,
1997; Freitas and Rocha, 2000; Almeida et al., 2005).
The above-described division, however, fails to fully account
for the complexity of peripheral T cell pools. Several other major
subpopulations should be considered, including populations of
CD4+FOXP3+ regulatory T cells (Sakaguchi, 2004), CD4+ and
CD8+ effector T cells, and the division of memory pools into
central-memory and effector-memory, which relies on differences
in migratory behavior and T cell differentiation status (Sallusto
et al., 2004).
REGULATORY CD4+CD25+FOXP3+ T CELLS: AN ESSENTIAL
POPULATION OF THE PERIPHERAL T CELL POOLS
The physiologic function of regulatory CD4+ T (Treg) cells is cen-
tral in establishing self-tolerance and in controlling autoimmune
diseases. These cells were initially identiﬁed in models of autoim-
mune disease or inﬂammatory bowel disease (IBD) following the
adoptive transfer of naïve T cells into lymphopenic animals, due
to their ability to prevent the provoked autoimmune manifesta-
tions (Powrie et al., 1993; Sakaguchi et al., 1995; Asano et al.,
1996; Sakaguchi, 2000; Maloy and Powrie, 2001). Treg cells specif-
ically express the transcription factor FOXP3, which is strictly
required for their development (Fontenot et al., 2003; Hori et al.,
2003). Indeed, carriers of spontaneous FOXP3 mutations – e.g.,
the IPEX (immunodysregulation, polyendocrinopathy, enteropa-
thy, x-linked) syndrome in humans (Wildin et al., 2001) and scurfy
mice (Blair et al., 1994; Bennett et al., 2001) – develop rapid and
lethal autoimmune syndromes that can be rescued upon transfer
of Treg cell populations (Fontenot et al., 2003; Hori et al., 2003).
Similar results were obtained in FOXP3-deﬁcient animals gen-
erated by homologous recombination (Fontenot et al., 2003) or
upon the selective ablation of Treg cells in adult mice (Kim et al.,
2007a; Lahl et al., 2007). However, CD4+ Treg cell actions can also
counter-productively suppress immune responses against tumors
and viral infections (Antony et al., 2005; Belkaid and Rouse, 2005),
indicating that regulatory T cells are capable of inﬂuencing all T
cell-mediated responses (Sakaguchi, 2004).
Others and we have shown that CD4+ Treg cells can prevent
IBD and autoimmune diseases caused by transfer of naïve CD4+
T cells into lymphopenic animals, as well as control the expan-
sion and regulate the total number of these T cells (Annacker
et al., 2000; Almeida et al., 2002). The critical role of CD4+ Treg
cells on peripheral T cell homeostasis was further demonstrated in
experiments with mouse chimeras reconstituted with bone mar-
row cells from CD25−/− (Almeida et al., 2002) or FOXP3−/−
(Fontenot et al., 2003) donors; the co-transfer of small numbers of
CD4+CD25+ Treg cells rescued these mice from massive lympho-
proliferation, autoimmunity, and death. Importantly, the rescued
chimeras exhibited normal absolute numbers of recovered T cells,
and relative proportions of naïve, memory, and effector CD4+
and CD8+ T cells were restored (Almeida et al., 2002; Fontenot
et al., 2003). These observations demonstrated that the lymphoid
hyperplasia observed in CD25−/− or FOXP3−/− mice was not cell
autonomous, and that restoring the CD4+ Treg population suf-
ﬁced to restore the equilibrium of the total peripheral T cell pool.
Furthermore,mice transgenic for FOXP3 overexpress the“scurﬁn”
protein and show an increased fraction of Treg cells within reduced
numbers of peripheral T cells (Khattri et al., 2001). We conclude
from these studies that the presence of CD4+ Treg cells is essen-
tial to the homeostasis of naïve, memory, and effector T cells.
Two important questions arise: (1) what mechanisms do regula-
tory T cells use to control CD4+ T cell numbers, and (2) how is
homeostasis of these regulatory T cells achieved?
FUNCTION OF CD4+ Treg CELLS: THE POSSIBLE ROLE OF IL-2
Previous studies have identiﬁed a vast number of putative mech-
anisms of suppression used by CD4+ Treg cells (Shevach, 2009).
Notably, these include both cell-contact dependent and indepen-
dentmechanisms, andwhile initial studies pointed to a segregation
into those categories according to the experimental system used,
with in vitro studies falling into the ﬁrst category and in vivo stud-
ies in the second, later studies have shown that both direct and
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indirect mechanisms may occur in vivo (Shevach, 2000). Indeed,
strong experimental evidence indicates that in vivo the suppressive
activity of Treg cells may be cell-contact dependent and APC-
mediated. Treg cells from mice deﬁcient in LAG-3 (a CD4-related
molecule that bindsMHCClass-II) show reduced regulatory activ-
ity (Huang et al., 2004). More importantly, recent ﬁndings using
Treg cells with a speciﬁc CTLA-4 deﬁciency indicate that CTLA-4
is required for Treg cells to suppress immune responses by dis-
rupting the ability of antigen-presenting cells to activate other T
cells (Wing et al., 2008). A hallmark feature of CD4+FOXP3+ Treg
cells is the expression of CD25, theα-chain of the high-afﬁnity IL-2
receptor (Nelson and Willerford, 1998); therefore, it has also been
proposed that the suppressive function of Treg cells could be due
to their higher ability to use available IL-2, which could prevent
IL-2 utilization by other naïve or effector cells that lack expression
of the high-afﬁnity IL-2 receptor (Barthlott et al., 2003; de la Rosa
et al., 2004).
This concept of suppression via IL-2 consumption was based
on the belief that IL-2 is a critical essential factor for T cell
responses and expansion, as supported by in vitro evidence (de
la Rosa et al., 2004). The dissociation kinetics, the directional-
ity of IL-2 production within the immunological synapse, and
the TCR-dependency of both IL-2 production and IL-2R expres-
sion all contributed to the notion of a requirement for proximity
between producers and users of IL-2, suggesting a role of IL-2
consumption in the mechanism of suppression (Malek and Cas-
tro, 2010). However, the view that IL-2 acts as a major growth
factor for in vivo T cell proliferation has since been challenged.
Indeed, IL-2−/−, IL-2Rα−/−, and IL-2Rβ−/− mice develop lym-
phoproliferative syndromes associated with both autoimmunity
and immunodeﬁciency (Kundig et al., 1993; Suzuki et al., 1995;
Willerford et al., 1995; Almeida et al., 2006b). In these mice the
strong activation state of T cells renders them refractory to further
in vitro stimulation and is responsible for an “immunodeﬁciency”
state. In IL-2R-deﬁcientmice disease canbepreventedby the trans-
fer of relatively small numbers of Treg cells (Almeida et al., 2002;
Malek et al., 2002). The increased lymphocyte proliferation and
the progressive accumulation of considerable numbers of T cells
observed argue against the strict requirement of IL-2 for T cell
expansion in vivo. It also suggests that other γc-chain dependent
cytokines, i.e., IL-15 and IL-7 or IL-7 alone in the case of the IL-
2Rβ−/− mice, could induce extensive T cell proliferation in vivo.
Nevertheless, it has also been shown that CD4+ T cell expansion
in response to antigen can occur in the absence of IL-2Rγ-chain
(γc) expression (Lantz et al., 2000). Moreover, mice deﬁcient in
STAT5, the transcription factor downstream of the IL-2R signal-
ing that has been reported to be critical for lymphocyte cell cycle
progression in vitro (Moriggl et al., 1999), also develop extensive
lymphoproliferation (Snow et al., 2003; Burchill et al., 2007; Yao
et al., 2007), suggesting that TCR signals alone or associated with
other γc-independent cytokines sufﬁce to elicit T cell expansion
in vivo. Overall these observations make apparent the discrepan-
cies between in vitro and in vivo studies and clearly demonstrate
that in vivo, TCR signals can bypass IL-2 requirements for CD4+
T cell proliferation and expansion. It should be pointed out that
although IL-2 does not seem to be strictly required for T cell prolif-
eration andprimary responses in vivo, as T cell responses have been
shown to resolve infection in the absence of IL-2 (Malek, 2008),
it appears to be critical in secondary responses, in particular for
the differentiation and development of CD8 T cell memory cells
(Williams et al., 2006) hinting to an impact of IL-2 in the quality
of the immune response rather than to an absolute requirement
for IL-2 in T cell responses. Thus the precise quantitative contri-
bution of IL-2 for CD4 T cell proliferation in vivo remains yet to
be established.
The observations that in vitro FOXP3+ Treg cells lacking CD25
retain intact suppressive capacities (Fontenot et al., 2005a) and,
more importantly, that a FOXP3 transgene restored Treg cell
function and protected against the onset of autoimmunity in IL-
2Rβ−/− mice (Soper et al., 2007), indicate that the suppressive
activity of Treg cells can occur in the complete absence of IL-
2 signals. Thus, it is likely that the suppressive activity of Treg
cells can occur both by inhibiting naïve T cell activation and
IL-2 production and possibly by inﬂuencing the response via
IL-2 consumption. Indeed, recent reports have suggested sup-
pression via IL-2 consumption by CD4+CD25+ Treg cells as a
mechanism of controlling immune responses in vivo (Chen et al.,
2011; Pandiyan et al., 2011). These studies may also be interpreted
as suggesting that Treg cells modify environmental factors and
immune responses to favor speciﬁc TH17 mimicking suppres-
sion of other T cell fates. Nevertheless, there exists a vast body
of evidence demonstrating other non-IL-2 related mechanisms
of Treg-mediated suppression, including IL-10-mediated regula-
tion of gut IL-17 responses (Chaudhry et al., 2011; Huber et al.,
2011), implying that not all Treg function is translated into TH17
responses by the suppressed effectors. It remains to be established
if these effects can occur simultaneously and what cues determine
the triggering of these diverse mechanisms.
HOMEOSTASIS OF REGULATORY CD4+ T CELLS: THE ROLE OF
IL-2
Our investigation of CD4+ Treg cell homeostasis revealed that the
absolute number of Treg cells and the ratio of non-Treg/TregCD4+
T cells are tightly regulated under steady-state in vivo conditions
(Almeida et al., 2006b). Adoptive transfer of a limited number
of CD25+ T cells rescues CD25−/− bone marrow (BM) chimeras
(Almeida et al., 2002), neonatal FOXP3sf mice (Fontenot et al.,
2003), and IL-2Rβ−/− mice (Malek et al., 2002) by reconstituting
a normal CD4+CD25+ Treg pool that persists indeﬁnitely with-
out new thymusoutput.Our strategy involvedmixedBMchimeras
that were reconstituted with precursor cells fromWT donors (that
were competent to generate CD4+CD25+ Treg cells) diluted at
different ratios with precursor cells from CD25−/− donors (that
were incompetent to generate CD4+CD25+ Treg cells). We found
that similar numbers and proportions of peripheral CD4+CD25+
Treg cells were recovered regardless of the fraction of precur-
sor BM cells that were competent to generate CD4+CD25+ Treg
cells (Almeida et al., 2006b). These ﬁndings and the constancy
of Treg cell numbers and proportions demonstrated that these
cells occupy a limited and specialized niche in the peripheral T
cell pool. The expression of CD25 (IL-2Rα) by the vast major-
ity of CD4+ Treg cells suggests a major role of IL-2 in CD4+
Treg biology. Indeed, mice that are genetically deﬁcient in IL-2
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(Schorle et al., 1991; Sadlack et al., 1995; Wolf et al., 2001), IL-
2Rα (Willerford et al., 1995), IL-2Rβ (Suzuki et al., 1995; Malek
et al., 2000), or STAT5 (the transcription factor downstream of
the IL-2R signaling; Snow et al., 2003; Burchill et al., 2007; Yao
et al., 2007) each lack sizeable populations of CD4+ Treg cells and,
consequently, develop lethal lymphoid hyperplasia and autoim-
mune diseases. Moreover, IL-2-dependent signaling is involved in
the maintenance of FOXP3 expression and in the maintenance
of the FOXP3-dependent gene signature, even at low levels of
IL-2Rβ-dependent signaling (Gavin et al., 2002; Hill et al., 2007;
Yu et al., 2009). Others and we have shown that IL-2 is essential
for the peripheral survival and expansion of CD4+CD25+ Treg
cells. Thus, Treg cells from IL-2-deﬁcient donors fail to survive
in IL-2−/− hosts (Almeida et al., 2006b) or to accumulate in the
periphery in the absence of IL-2R signals (Almeida et al., 2002,
2006b; Fontenot et al., 2005b), and blocking IL-2R or neutralizing
IL-2 reduces Treg cell numbers (Bayer et al., 2005; Setoguchi et al.,
2005).
The observation that CD4+CD25+ T cell numbers and propor-
tions are remarkably stable does not explain how CD4+CD25+
Treg homeostasis is achieved or the mode of action of IL-2. Par-
simony suggests that the expression of high-afﬁnity IL-2Rα and
the dependence on IL-2 for survival are critical and connected
clues to understanding the homeostasis of the Treg cell subpop-
ulation. We showed that expression of high levels of high-afﬁnity
IL-2Rα specializes the CD4+CD25+ Treg cells for exploiting the
IL-2 resource in vivo. In fact, in the CD4+ T cell pool of mouse
chimeras reconstituted with a mixture of precursors differing only
in their potential to exploit IL-2, the WT CD4+ T cells that are
able to express CD25 have a noticeable seeding advantage over the
CD25−/−CD4+ cells (Almeida et al., 2006b). Thus, CD25 expres-
sion by Treg cells permits them to occupy a niche deﬁned by the
IL-2 resource, and allows them to avoid direct competition with
other CD4+ T cells that do not express the high-afﬁnity IL-2Rα.
This explains how the immune system ensures the presence of this
subpopulation of cells, but it fails to explain their constancy or
their relative proportion.
We have shown that complementation chimeras reconstituted
with a mix of donor BM from CD25−/− and IL-2−/− animals
present a normal peripheral T cell pool, including a normal pro-
portion of CD4+CD25+ Treg cells (Almeida et al., 2002). This
indicates that paracrine IL-2 is sufﬁcient for the peripheral survival
of CD4+CD25+ Treg cells. We also reported that, in steady-state
conditions, establishment of a fully sized and functional Treg cell
population that is capable of preventing development of autoim-
mune syndromes only occurs in the presence of IL-2-competent
αβ T cells (Almeida et al., 2006b). This suggests that αβ T cells
(particularly activated CD4+ T cells) represent the major source
of the IL-2 required for the survival of a functional population of
Treg cells in the peripheral pools (Curotto de Lafaille et al., 2004;
Setoguchi et al., 2005; Almeida et al., 2006b). We have also used
transgenic mice overexpressing IL-7 to greatly increase periph-
eral T cell numbers recovered at equilibrium time-points, and we
found that the numbers of CD4+CD25+ Treg cells increased pro-
portionally to the absolute number of CD4+ T cells (Almeida
et al., 2006b). Since CD4+ Treg cells are unable to produce IL-2
(Shevach, 2000) due to active FOXP3-dependent repression of the
il2 gene (Wu et al., 2006; Ono et al., 2007), the corollary conclu-
sion from these observations is that Treg cells are reliant on other
IL-2-producing T cells for survival. To demonstrate this point,
we reconstituted irradiated Rag2−/−IL-2−/− hosts with mixes of
IL-2-sufﬁcient and IL-2-deﬁcient BM cells, and we found a direct
correlation between the numbers of IL-2-competent cells and
CD4+ Treg cells (Almeida et al., 2006b). We concluded that the
size of the Treg niche corresponds to the available quantity of IL-
2, meaning that the number of CD4+CD25+ Treg cells is tied to
the number of IL-2-producingCD4+ T cells. This explainswhy the
relative proportion of the two populations is stably maintained.
Importantly, the size of the IL-2 niche is not ﬁxed by factors exter-
nal to the overall T cell pool; instead, it is mainly dependent on
IL-2 produced by other T cells (Almeida et al., 2006b).
This mechanism of homeostasis implies that the survival of a
given Treg and the capacity for expansion will be dependent on
the amounts of IL-2 produced by other T cells and, thus, Treg cells
are capable of extended expansion and renewal when faced with
an empty Treg niche. Indeed, when very low numbers of Treg cells
are co-transferred with IL-2-producing CD4+ T cells into lym-
phopenic animals, they expand considerably and tend to occupy
the vacant CD4+ Treg niche (Almeida et al., 2006b; Komatsu et al.,
2009). A similar situation occurs in the ﬁrst days of life, as the
ﬁrst wave of CD4+ Treg cells expand considerably between days 3
and 7 (Bayer et al., 2005). Interestingly, the capacity of expansion
of “converted” or CD25low-expressing FOXP3+ contaminants in
transfers of CD4+CD25− T cells is greatly affected by the presence
of CD4+CD25+ co-transferred cells, suggesting strong competi-
tion for the occupancy of theTregniche and further demonstrating
that initial CD25 expression is a major competitive advantage in
IL-2 usage (Almeida et al., 2006a).
QUORUM-SENSING AND CD4+ T CELL HOMEOSTASIS
It is believed that control of lymphocyte numbers may be deter-
mined by cellular competition for a limited amount of resources,
e.g., trophic factors required for survival (Freitas andRocha,2000).
However, it is not clear what mechanisms are used to control
expanding lymphocyte numbers in situations where resources are
not limiting, e.g., during immune responses or an excess of self-
antigens or cytokines. It remains unanswered how lymphocyte
populations “count” the number of their individuals and how do
they “know” when to stop growing?
Many species of bacteria use quorum-sensing mechanisms to
coordinate their gene expression according to their population
density (Miller and Bassler, 2001; Diggle et al., 2007). A similar
quorum-sensing-like mechanism may play a critical role in lym-
phocyte homeostasis, if lymphocytes can assess the number of
molecules with which they interact and respond accordingly once
a threshold number of molecules is detected.
We propose that control of lymphocyte numbers could be
achieved by the ability of lymphocytes to perceive their own
population density (de Freitas, 2009). The correlation between
the numbers of CD4+CD25+FOXP3+ Treg cells and of activated
IL-2-producing T cells indeed suggests the presence of a quorum-
sensing-like mechanism. In this case CD4+ T cell populations use
the Treg cell subset expressing the high-afﬁnity IL-2Rα-chain to
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FIGURE 1 | (A) Quorum-sensing. The presence of IL-2 and the ability of the
Treg cells to detect its levels are crucial to the homeostasis of the immune
system. Quorum-sensing in this case is deﬁned as an indirect feedback loop
where the IL-2 produced by a subpopulation of activatedT cells (among
others) is detected (sensed) by a subpopulation of CD4+ Treg cells expressing
the high-afﬁnity IL-2Rα-chain; these cells contribute to controlling the number
of CD4+ T cells. In other words, the overall CD4+ T cell populations sense the
produced quantities of IL-2 and adapt their behavior accordingly. (B) Failure of
quorum-sensing by defective sensor molecule. The inability to detect IL-2
because of defects in IL-2R expression (in IL-2Rα−/− or IL-2Rβ−/− mice) or
signaling (in STAT5−/− mice) leads to lymphoid hyperplasia and autoimmune
disease. (C) Failure of quorum-sensing due to absence of the sensed
molecule. In the absence of IL-2, Treg cells do not survive, which causes
lymphoid hyperplasia and autoimmune pathology.
monitor the number of activated CD4+ T cells by detecting (sens-
ing) the IL-2 produced, and they adapt their collective behavior
according to the quantities of IL-2 sensed (Figure 1A). In this
manner, CD4+ T cells may be able to control not only the num-
ber of activated IL-2-producing CD4+ T cells, but also the size of
the total CD4+ T cell pool. Thismechanismprevents uncontrolled
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lymphocyte proliferation andmaintains a constant pool size. Thus,
according to the quorum-sensing hypothesis, IL-2, rather than
being a mere growth factor required for the proliferation of some
T cells, represents a key molecule playing a central role in CD4+ T
cell homeostasis.
We hypothesize that failure of this quorum-sensing mechanism
results in uncontrolled CD4+ T cell activation and autoimmune
disease. The inability of CD4+ T cells to detect IL-2 – due to defects
of IL-2R expression (Willerford et al., 1995; Malek et al., 2000) or
IL-2 signaling (Burchill et al., 2007), or due to failure to produce
IL-2 (Schorle et al., 1991) – leads to lymphoid hyperplasia and
lethal autoimmune disease (Figures 1B,C). Other autoimmune
diseases are also linked to defects in the IL-2/IL-2R signal path-
ways. Autoimmunity in NOD mice seems to be dependent on
lower IL-2 production resulting from genetic defects that map to
the il-2 region (Yamanouchi et al., 2007). Polymorphisms linked
to IL-2 receptors, IL-2Rα and IL-2Rβ, are associated with several
autoimmune diseases, such as type 1 diabetes, multiple sclerosis,
celiac diseases, and rheumatoid arthritis (Gregersen and Olsson,
2009; Todd, 2010). It has also been reported that Dicer, the enzyme
responsible for generating functional miRNAs, enhances Treg cell
development (Cobb et al., 2006). FOXP3 regulates miR155 expres-
sion andoptimizes Treg cell responses to limiting quantities of IL-2
by targeting suppressor of cytokine signaling 1 (SOCS1) expres-
sion (Lu et al., 2009; Stahl et al., 2009). Consequently, the selective
disruption of miRNAs in the Treg cell lineage results in lethal
autoimmunity (Liston et al., 2008; Zhou et al., 2008). However,
it should be noted that genetic risk for autoimmunity might be
more complex than the IL-2 regulation of Treg cell function, as
it may also involve increased responses of the self-reactive clones
to IL-2.
By modifying IL-2 levels it should be possible to increase Treg
cell numbers and control auto-reactive immune responses. How-
ever, IL-2 also contributes to the effector armof immune responses
by driving CD8+ T cell proliferation and differentiation into effec-
tor functions (Kalia et al., 2010; Pipkin et al., 2010; Zaragoza
et al., 2011) and development of CD8+ T cell memory (Williams
et al., 2006). Treg cells have a major competitive advantage for
IL-2 usage (Almeida et al., 2006b); this is due to the constitutive
expression of the high densities of the IL-2Rα chain that confers
a up to 1000-fold increase of afﬁnity of binding to the IL-2Rα, β,
γ trimer (Feinerman et al., 2010), the fact that even a low level
of IL-2-dependent signaling sufﬁciently ensures maintenance of
FOXP3 expression (Gavin et al., 2002; Hill et al., 2007; Yu et al.,
2009), and because FOXP3 expression itself optimizes Treg cell
responses to limiting quantities of IL-2 (Lu et al., 2009; Stahl et al.,
2009). Therefore, Treg cells should be particularly susceptible to
small increases in IL-2 availability. Indeed, administration of low
doses of IL-2 (Tang et al., 2008; Grinberg-Bleyer et al., 2010) or
inducible adenovirus bearing IL-2 genes (Goudy et al., 2011) can
reverse disease or prevent diabetes in NOD1 mice by increas-
ing Treg cell numbers in the target organs. Some anti-IL-2/IL-2
immune complexes have been used in vivo to prolong the half-
life of the administered cytokine (Boyman et al., 2006), and can
selectively favor Treg cell expansion by blocking the IL-2 bind-
ing site to the IL-2Rβ (Boyman et al., 2006; Webster et al., 2009).
Differences in the IL-2R signaling pathways between Treg and T
effector cells may also allow manipulation of responses to either
favor or antagonize Treg function (reviewed by Malek and Castro,
2010).
Feedback loops between interacting effector and regulatory
cells have been proposed to occur in the course of immune
responses (Knoechel et al., 2005; Fehervari et al., 2006; Carneiro
et al., 2007). However, these previous models describing regu-
latory feedback loops between Teff/Treg cells did not take into
consideration the protagonist part of IL-2 and Treg cells in overall
lymphocyte homeostasis. The quorum-sensing hypothesis extends
beyond the scope of speciﬁc immune responses and predicts the
behavior of the global T cell pool, including maintenance of the
naïve pool and control of the size of the activated T cell pool.
Indeed, the effects of the absence of IL-2 and/or of the Treg cell
subset extend to all subpopulations on the CD4+ T cell pool sug-
gesting that this homeostatic mechanism acts to maintain total T
cell numbers rather than the size of effector and regulatory T cells
only. The quorum-sensing hypothesis, besides its proposed overall
role on T cell homeostasis, also embodies a feedback mechanism
to control T cell activation while allowing immune responses to
occur; this likely plays a part in the contraction phase of the CD4+
T cell responses. In the initial stages of an immune response,
the presence of antigen perturbs the immune system equilibrium
and incites proliferation of antigen-speciﬁc cells. Upon activa-
tion, the number of IL-2-producing cells (T and non-T) and
the IL-2 concentrations increase; Treg cells respond with prolif-
eration, and eventually re-establish a steady-state by suppressing
further T cell activation and proliferation, thus decreasing the
number of IL-2-producing cells. Such a mechanism might have
evolved to control peripheral cross-reactive or auto-reactive T
cell clones, while allowing controlled increases in overall periph-
eral T cell number. This mechanism deﬁnitively enables CD4+
T cells to limit their expansion when in presence of an excess of
resources.
In conclusion our quorum-sensing model provides new mech-
anistic insights and has implications for understanding autoim-
mune disease and will create a new way of thinking about the
homeostasis of lymphocyte populations.
PROPOSED MATHEMATICAL MODEL FOR THE ROLE OF
“QUORUM-SENSING” IN CD4+ T CELL HOMEOSTASIS
Based on the suggested quorum-sensing hypothesis we here pro-
pose a mathematical model that is intended to describe in a
quantitativeway the role of IL-2 and quorum-sensingmechanisms
in CD4+ T cell homeostasis. This model describes CD4+ T cell
dynamics, that is the time evolution of four different CD4+ T cell
subsets: naïve (n1), IL-2-producing (n2), activated/memory non-
IL-2-producing (n3), and regulatoryCD4+ T cells (n4). Themodel
assumes that cells can divide,differentiate, or die. The assumptions
of the model are as follows.
THYMUS OUTPUT
We model thymus output as occurring at a constant rate, inde-
pendent of the number of cells in the peripheral CD4+ T cell
population. We only consider thymus output for naïve and
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regulatory T cells. These terms take the form
+ vi ,
where i = 1, 4.
NATURAL DEATH
We assume that CD4+ T cells possess a natural death rate and that
this constant death rate depends on the T cell subset. Thus, the
death terms are proportional to the population size of each subset,
namely
−μini ,
where i = 1, 2, 3. We have already discussed the requirement for
IL-2 for the survival of regulatory T cells. This can be encoded as
an IL-2-dependent death term for the subset of regulatory T cells.
We do not directly include a dynamical equation for IL-2 levels,
but we assume that the IL-2 levels are proportional to the number
of IL-2-producing cells. The death term for the regulatory T cells
takes the form
−μ4 κ2
κ2 + n2 n4,
where κ2 is the number of IL-2-producing cells at which the death
rate for regulatory cells is half its value in the absence of any IL-2.
TCR/IL-7-INDUCED PROLIFERATION
We assume that all T cell subsets proliferate in response to TCR-
and/or IL-7-mediated signals; thus, we include them as logistic
growth terms with carrying capacity κ. In this way, we impose a
limit on the population size that these signals can sustain, which
is consistent with the idea that T cells must compete for such sig-
nals in the periphery. The proliferation due to TCR and IL-7 takes
the form
+λiTCRni
(
1 − ni
κ
)
where i = 1, 2, 3.
IL-2-INDUCED PROLIFERATION
In addition to growth terms due to TCR and/or IL-7 stimulus we
also include proliferation terms to model T cell responses to IL-2.
For a given T cell subset (except for naïve T cells), the growth rate
due to IL-2 signals is assumed to be proportional to the number of
IL-2-producing cells. We model IL-2-induced proliferation with
quadratic terms of the form
+λi IL − 2n2ni
where i = 2, 3, 4.
DIFFERENTIATION OF NAÏVE T CELLS
Naïve T cells can be activated in response to their speciﬁc antigen.
We model this differentiation by assuming naïve T cells become
IL-2-producing cells at a constant rate α12. We also assume naïve
T cells differentiate into memory cells at a constant rate α13. These
assumptions are modeled by terms of the form
±α1in1
where i = 2, 3.
DIFFERENTIATION OF IL-2-PRODUCING CELLS
We assume IL-2-producing cells stop producing IL-2 at a constant
rate α23 and thereafter differentiate to the activated/memory pool.
This term is written as
±α23n2.
REACTIVATION OF MEMORY
We assume that memory T cells can become IL-2-producing cells
in response to further stimulation by their speciﬁc antigen. This
assumption is modeled by a term of the form
±α32n3.
SUPPRESSION
We encode regulatory T cell suppression as follows: regulatory T
cells give a signal to activated IL-2-producing T cells that causes
them to stop producing IL-2. We model this as a contact term pro-
portional to the number of regulatory T cells, with the assumption
that IL-2-producing cells may become memory cells after hav-
ing received this signal. The assumption is modeled by a term of
the form
±βn2n4..
SYSTEM OF ODEs
Based on the assumptions introduced above,we can write a system
of ordinary differential equations (ODEs) that fully describes the
model. The ODEs are given by
dn1
dt
= v1 − μ1n1 + λ1TCR n1
(
1 − n1
κ
)
− α12n1 − α13n1,
dn2
dt
= −μ2n2 + λ2TCR n2
(
1 − n2
κ
)
+ λ2IL−2n2n2 + α12n1
− α23n2 + α32n3 − βn2n4,
dn3
dt
= −μ3n3 + λ3TCR n3
(
1 − n3
κ
)
+ λ3IL−2n2n3 + α13n1
+ α23n2 − α32n3 + βn2n4,
dn4
dt
= v4 − μ4 κ2
κ2 + n2 n4 + λ4IL−2n2n4.
We note that a detailed mathematical analysis of this system
of ODEs (existence and stability of steady-states, for example) is
beyond the scope of this paper and will be explored in a separate
publication.
The mathematical model introduced in this section assumes
that the limiting factors mediating the expansion of the CD4+
Treg population are not only the available levels of IL-2, but also
the number of IL-2-producing cells. Implicit in this assumption
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is that upon the encounter of an IL-2-producing T cell and a Treg
cell, the strength of the signal which can be delivered via IL-2 is
non-limiting; indeed the limiting factor is the rate at which such
encounters occur. Thequorum-sensingmechanismdescribedhere
can be understood as follows: Treg cells “count” and regulate the
numbers of activated T cells through the detection of the IL-2
and the number of interactions between these two populations,
of which a speciﬁed proportion (encoded within the parameters
of the model) leads to cellular events such as a division, survival,
or suppression. Previous mathematical models have explored the
consequences of different mechanisms for the action of Tregs
on IL-2-producing cells (usually called effector T cells). In the
model presented here, the suppression mechanism (represented
by the term proportional to β) is mathematically encoded as a
non-linear density dependent term in the equation of motion
for the IL-2-producing cells. Naive T cells, at a rate proportional
to the number of Treg cells and to β, become activated/memory
cells. Such a suppressive mechanism is in contrast to previously
studied mechanisms where the action of Treg cells is to consume
available IL-2, thus limiting the number of survival or prolifera-
tive signals cells within the CD4+ T cell population can receive.
We believe that our approach is more robust since the action
of Treg cells is assumed to limit the number of cells which are
activated and produce the resource IL-2, rather than try to limit
the IL-2 resource itself by consumption of IL-2 post-production.
Whilst it has been extensively shown that Treg cells are critically
dependent on IL-2 for their survival and proliferation, it is not so
clear whether IL-2-producing cells are solely dependent on IL-2
for their own expansion. In our model, we encode two possible
mechanisms of expansion for the IL-2-producing (effector) pop-
ulation, one of which is IL-2 independent. In such a scenario, the
action of Treg cells focused around consumption of IL-2 would
only serve to limit one of these two mechanisms for expansion
of the IL-2-producing T cell population. By assuming that the
suppressive action of Treg cells prevents overall T cell activation
and proliferation, the degree of expansion through either path-
way is controlled, and thus both populations, are indexed to each
other.
PLOTS
We conclude with a series of plots of the deterministic trajectories
of the above system of equations as well as with realizations of
a stochastic version of the deterministic model. It must be noted
that we neglected thymus output terms (v1 = 0 and v4 = 0). Ini-
tial conditions were 100 naïve CD4+ T cells and 10 Treg cells. We
choose parameter values to simulate the dynamics of a clone of
CD4+ T cells in response to antigenic challenge, starting at time
t = 0. The parameter values are given in Table 1. In order to make
the mathematical model more realistic we have also assumed that
naïve T cells differentiate progressively with cell division, i.e., they
differentiate after they have divided at least three times. Addition-
ally, we assumed that IL-2-producing cells only differentiate into
activated/memory cells if they have divided at least three times.
Suppression still acts across every generation of IL-2-producing
cells, and memory cells are free to become IL-2-producing cells
without any requirements for prior division. In the simulations
Table 1 | Parameter values and dimensions for a quorum-sensing
model of CD4T cell homeostasis.
Parameter Value Units
μ1 1×10−3 h−1
μ2 1×10−2 h−1
μ3 1×10−2 h−1
μ4 1×10−2 h−1
λ1TCR 2×10−2 h−1
λ2TCR 2×10−2 h−1
λ3TCR 5×10−2 h−1
λ2IL−2 5×10−5 Cell−1 h−1
λ3IL−2 2×10−5 Cell−1 h−1
λ4IL−2 1×10−4 Cell−1 h−1
κ 1×103 Cell
κ2 1×101 Cell
α12 1×10−1 h−1
α13 1×10−2 h−1
α23 1×10−2 h−1
α32 1×10−3 h−1
β 2×10−4 Cell−1 h−1
this is achieved by keeping track of the generation each cell belongs
to (by writing an ODE for each respective generation) and keep-
ing parameter values constant across all generations with the
exception of those parameters, which are generation-dependent.
The deterministic solutions were simulated over periods of 2 and
8weeks, respectively, are shown in Figure 2. We also present real-
izations from a stochastic version of the same deterministic model
(Figure 3), with simulations run over the same time windows as
the deterministic trajectories. The stochastic realizations shown
here were produced using the Gillespie algorithm. The system
of ODEs was solved using a fourth-order Runge–Kutta scheme.
Initially, the model shows slow growth in the number of T cells;
during the ﬁrst 2 days, the total cell population approximately dou-
bles from around 100 cells to 200 cells, with the immune response
reaching a peak and at around day 7. At days 4–5 there is a sharp
increase in the number of IL-2-producing cells, followed by a sub-
sequent increase in thenumber of antigen-experienced cells,which
are not producing IL-2. Notably, this leads to a large increase in
regulatory cells around day 7, which is immediately followed by a
sharp contraction phase that lasts around 2 days. A slower contrac-
tion phase that lasts around 3weeks follows before a homeostatic
equilibrium is reached. We note that for this parameter set the
regulatory T cell subset takes longer to reach equilibrium than the
memory T cell subset.
At equilibrium, the model predicts that the size of the memory
T cell population is limited only by the availability of TCR/IL-7
signals, which is included in the model as the carrying capac-
ity κ. This population acts as a source for the population of
IL-2-producing cells, so that there is a small but constant sup-
ply of IL-2-producing cells at equilibrium. This source of IL-2
is then sufﬁcient to maintain a regulatory T cell population,
which in turn keeps the IL-2-producing population from expand-
ing. The deviation away from this ratio of regulatory T cells
and IL-2-producing cells allows the model to reproduce the key
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FIGURE 2 |Trajectories of the deterministic model for the parameter
set given inTable 1, with the following initial conditions: 100 naïve
cells (blue) and 10 regulatory cells (red). (A) Data shown over a time
course of 2weeks. The immune response peaks at ∼7days, then declines
to a homeostatic equilibrium dominated by memory cells. (B) Data shown
over a time course of 8weeks. The contraction phase occurs over an
extended time period of ∼20days for memory cells and ∼40days for
regulatory cells.
characteristics of the immune peak and the contraction phase
before settling down to equilibrium. Indeed, it is possible to simu-
late a larger immune peak by specifying a larger ratio between
naïve cells and regulatory cells in the initial conditions, or to
dampen the immune peak by changing the ratio in the opposite
manner.
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FIGURE 3 | Realizations of the stochastic model carried out using the
Gillespie algorithm. All parameters and initial conditions are the same as in
the deterministic model, with (A,B), respectively, correlating to (A,B) from
Figure 2. There is a higher degree of noise at equilibrium for memory cells,
which is due to memory cells repeatedly receiving antigen-mediated signals
to become IL-2-producing, then reverting back to a non-IL-2-producing state.
In our model, we assumed that antigen is constant (encoded
in the proliferation parameter λiTCR) and non-limiting; however,
an effective immune response should serve to remove antigen.
We could address this issue by either introducing time-dependent
rates for the activation of naïve or memory cells, or by intro-
ducing within the rates a dependence on a number of cells that
would be linked to the antigen-clearance rate, e.g., effector cells.
We have also assumed that naïve T cells may only be activated
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after having proceeded through at least three divisions, and equiv-
alently IL-2-producing cells are assumed to only revert back to a
non-IL-2-producing state if they have gone through three divi-
sions. In reality, the division/proliferation-linked differentiation
program is unlikely to be so clear-cut. We could reﬁne the model
by introducing a probabilistic differentiation based on genera-
tion, where cells are increasingly likely to differentiate as they
progress through more divisions. The model we introduce here
has been applied only to the pool of speciﬁc T cells that can play
a part in response to their cognate antigen. The model could be
extended to mirror the effect this immune response would have
on a bystander population of T cells that is not involved in the
immune response. We note that our model can also be applied
to model T cell homeostasis with a different set of parameter
values. However, this is beyond the scope of what we wish to
present here.
Based on single-cell in vitro experiments, Feinerman et al.
(2010) recently developed a quantitative model for the regulation
of immune responses by IL-2 – in particular, for the competition
for IL-2 between effector and regulatory CD4+ T cells during
an immune response. They discuss how binding of IL-2 leads
to IL-2Rα up-regulation in both effector and regulatory cells.
Regulatory cells express higher basal IL-2Rα levels, which gives
them a distinct advantage over effector cells in the ability to scav-
enge IL-2. This advantage reportedly allows regulatory cells to
critically limit the amount of IL-2 available for consumption by
effector cells. The authors develop a biochemical computational
model of IL-2R and STAT5 signaling, which takes into account
the cell-to-cell variability in IL-2 receptor expression levels, as well
as a dynamical model of IL-2 competition between regulatory
and effector T cells. Similarly, Busse et al. (2010) introduced a
reaction-diffusion model to describe the spatio-temporal dynam-
ics of IL-2, and regulatory and helper T cells. Their model captures
the interplay between IL-2 production, binding, internalization,
degradation, and recycling after antigen stimulation; it is based
on the positive correlation between IL-2 binding and cell-surface
number of IL-2Rα. The authors conclude that IL-2-induced up-
regulation of high-afﬁnity IL-2R establishes a positive feedback
loop of IL-2 signaling. Furthermore, under conditions of limit-
ing IL-2, their results indicate that regulatory T cells can deprive
moderately stimulated helper T cells of IL-2 (Busse et al., 2010).
It is important to note, however, that antigen-speciﬁc CD4+ T
cells expand in the absence of the IL-2Rγ-chain (Lantz et al.,
2000) and that a FOXP3 transgene restored Treg cells and pro-
tected against autoimmunity in Il-2Rβ−/− mice (Soper et al.,
2007), both observations indicating that expansion of effector
cells can occur in the absence of IL-2 and the suppressive activity
of Treg cells can occur in the absence of IL-2 consumption and
signaling.
In contrast, the model that we propose here does not include
competition for IL-2 at the receptor/molecular level; however, in
choosing the parameters, we imposed λ4IL-2>λ2IL-2. Implicit
in this inequality is the fact that regulatory T cells are more sensi-
tive to IL-2 than IL-2-producing cells (Gavin et al., 2002; Almeida
et al., 2006b; Hill et al., 2007; Lu et al., 2009; Stahl et al., 2009; Yu
et al., 2009), but we do not assume that this limits the proliferative
capacity of IL-2-producing cells. In our model, the limiting factor
of proliferation for IL-2-producing cells is the number of cells
themselves, for which regulatory cells play a major role through
the suppressive term β.
Recent experimental work by Quiel et al. (2011) and mathe-
matical work by Bocharov et al. (2011) provide a model based
on the observation that the number of antigen-speciﬁc cells after
immunization is not proportional to the number of precursors,
and that the factor of expansion decreases as the number of pre-
cursors increases. The authors speculate that this phenomenon is
due to crowding effects, and use a deterministic model with four
CD4+ T cell populations that differ in their maturation and differ-
entiation states (Bocharov et al., 2011). The authors assume that
differentiated non-dividing T cells impose a feedback mechanism
on less mature dividing T cells, which acts to increase the dif-
ferentiation rates of these less mature cells, thereby limiting their
proliferative capacity. This differs from our model, where prolif-
eration will continue “unchecked” in the absence of regulatory
cells.
There is already a large body of work devoted to the devel-
opment of mathematical and computational models to study
the dynamic interactions between the populations of Treg cells
and effector CD4+ T cells. Early work focused on investi-
gating different potential mechanisms of interaction between
Treg cells and effector cells (Leon et al., 2003; Carneiro et al.,
2007), occurring at conjugation sites present on the surface
of antigen-presenting cells (APCs; Tang et al., 2006). Thus,
Treg cells are assumed to be reliant on paracrine cytokines for
their clonal expansion, and it is thought that IL-2 is the criti-
cal cytokine required for this expansion (Almeida et al., 2002,
2006b; Malek et al., 2002; Curotto de Lafaille et al., 2004; de
la Rosa et al., 2004; Setoguchi et al., 2005). The “crossregula-
tion model” explores the mathematical consequences of several
of these assumptions, particularly the mechanisms by which Treg
cells limit the proliferative capacity of effector cells (Carneiro et al.,
2007).
Finally, we should mention other mathematical modeling
efforts that have included bystander T cell activation (Kim et al.,
2007b; Burroughs et al., 2011). Burroughs et al. (2011) make use
of a dynamical systems approach to model a regulatory T cell
population, a population of effectorT cells that have receivedAPC-
mediated antigenic stimulus, and a bystander T cell population
that is unresponsive to the antigen. The authors conclude that
autoimmune conditions can arise following a primary immune
response due to a bystander T cell population and that the equilib-
riumof the immune systemdepends on a balance between effector
and regulatory T cell populations.
In conclusion, we have introduced a quantitative mathemati-
cal model of quorum-sensing for CD4+ T cell homeostasis. The
model includes thymus output, cellular proliferation (TCR/IL-
7 and IL-2-induced), differentiation and suppression, as well as
death, linked to the levels of IL-2-producing cells in the case of
regulatory T cells. The model has been used to explore the dynam-
ics of CD4+ T cells during an immune response. Our results
(Figures 2 and 3) show that there is a sharp increase in the num-
ber of IL-2-producing cells at days 4–5, followed by an increase in
the number of activated/memory non-IL-2-producing cells. This
leads to a large increase, around day 7 (which corresponds to the
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peak of the response) in the number of regulatory T cells, which
is then followed by a sharp contraction phase that lasts around
2 days. Steady-state conditions or homeostasis are reached after a
slower contraction phase that lasts around 3weeks. Key features
of the model are: (i) IL-2-producing cells, which correlate with
IL-2 levels, dictate the proliferation rate of regulatory T cells and
(ii) regulatory T cells control IL-2-producing cell differentiation to
non-IL-2-producing cells. These two terms guarantee that CD4+
T cells are able to restrain their own proliferation by “sensing” the
number of IL-2-producing cells, and thus preventing unbounded
lymphocyte division as well as controlling the number of activated
T cells and the total CD4+ T cell population.
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